AIM Dental Marketing

Sex, Drugs and Oral Cancer

Presenter: Robert Whitman, MSE – CEO of Forward Science

Recent trends in oral cancer have heightened the importance of a proper oral cancer screening protocol for all medical and dental professionals.

The incidence of oral cancer has increased each of the past seven years.  This deforming and sometimes deadly disease is now affecting patients with no traditional risk factors.

Owing to the 225% increase in HPV-related orapharyngeal cancers, oral cancer is occurring in younger populations, changing the perception of who is an appropriate screening candidate.  This strongly suggests the need for a new adjunctive oral cancer screening protocol

The webcast introduces recent and emerging technologies for the early discovery of oral cancer, including fluorescence technology and quantitative cytology, as well as their proper implementation.

Clinical examples of these procedures are presented.

As cancer therapies continue to evolve, two oral health concerns from many such treatments are xerostomia and mucositis. Other common side effects and treatment options for the oncology patient are covered.

Our presenter, Robert Whitman, is a graduate of Tulane University with a B.S. and M.S.E. in Biomedical Engineering, He brings a unique mindset to the medical device industry. As a Clinical Engineer at M.D. Anderson Cancer Center, Robert had a passion for early cancer diagnostics, He joined the R & D team at a private startup, developing cancer-screening products using fluorescence technology licensed from M.D. Anderson Cancer Center and later co-founded Forward Science LLC, a medical device company established with the goal of advancing oral healthcare through early discovery, diagnostics, , and treatment options. He is now their CEO and speaks on the topics of oral cancer and early discovery.

Rob shares: details on oral cancer rates and risk factors, the role of HPV in Oral Cancer, proper patient communication and oral screening protocols, and how to use adjunctive screening technology.

AIM MarketingSex, Drugs and Oral Cancer